concurrent chemoradiotherapy without brachytherapy in locally advanced cervical cancer: a phase ii clinical trial
نویسندگان
چکیده
background and objective: concurrent chemoradiotherapy (ebrt + cisplatin) plus intracavitary brachytherapy is the standard of care in patients with advanced cervical cancer. however, some patients are unable to undergo brachytherapy due to massive residual tumor or anatomical distortion. in this study, we evaluated the treatment outcome in patients with locally advanced cervical cancer undergoing conventional ebrt plus cisplatin based chemotherapy. method: in this prospective phase 2 trial, we selected patients with locally advanced cervical carcinoma (stage: iib to iiib) undergoing external beam radiotherapy and chemotherapy without brachytherapy at our institute between oct. 2007 and oct. 2009. the patients received 50 gy in 5 weeks to whole pelvic followed by a localized boost dose on tumor to 70 gy concurrently with cisplatin 35 mg/m2 weekly. the treatment related toxicities and survival (overall and disease free) were evaluated. results: 30 cases with a median age of 55 (range; 40 to 73) were studied. according to figo classification, the clinical stages were as follows: stage: iib 23, iiia 4, and iiib 3 cases. three months after treatment, 19 patients (63.3%) achieved complete response. with a median follow up time of 18 months (range; 10-33 months), 8/23 cases (34.7%) with stage iib and 2/7 (28.5%) among stage iiia-iiib remained disease free at the end of follow up. data showed a 2-year overall survival rate of 58.7% ± 9% and 2- year disease free survival of 37.7% ± 9% . most toxicities were grade i and ii. 2 (6.6%) grade iii diarrhea and 4 (13.3%) grade iii neutropenia were recorded. conclusion: although a considerable number of patients achieved complete response using concurrent chemoradiotherapy without brachytherapy, the overall treatment outcomes especially for stage iiia-iiib were unsatisfactory. using modern radiation therapy techniques with increased delivered boost dose might improve treatment results.
منابع مشابه
Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer
BACKGROUND Concurrent chemoradiotherapy (EBRT + cisplatin) plus intracavitary brachytherapy is the standard of care in patients with advanced cervical cancer. However, a number of patients could not undergone brachytherapy due to massive residual tumor or anatomical distortion. In this study, we have evaluated the treatment outcome in patients with locally advanced cervical cancer, undergone co...
متن کاملResponse to neoadjuvant chemotherapy in locally advanced gastric and gastroesophageal cancer: Phase II clinical trial
Background: Gastric cancer is an important health problem across the world. Chemotherapy in combination with local treatment is standard treatment for locally advanced gastroesophageal cancers. The purpose of this investigation was evaluation of response and tolerability to neoadjuvant EOX regimen in locoregionally advanced gastric cancer. Materials and Methods: patients with locoregionally adv...
متن کاملMulti-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
PURPOSE To evaluate the toxicity and efficacy of concurrent chemoradiotherapy using weekly cisplatin for patients with locally advanced cervical cancer in East and Southeast Asia, a multi-institutional Phase II clinical study was conducted among eight Asian countries. METHODS AND MATERIALS Between April 2003 and March 2006, 120 patients (60 with bulky Stage IIB and 60 with Stage IIIB) with pr...
متن کاملExtrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma
OBJECTIVE To evaluate whether adjuvant simple hysterectomy after concurrent chemoradiotherapy (CCRT) improves progression-free survival (PFS) compared with current standard care in locally advanced cervical adenocarcinoma (LACAC). METHODS We reviewed a cohort of 55 patients with LACAC (International Federation of Gynecology and Obstetrics [FIGO] stage IB2, IIA2, IIB, III without distant metas...
متن کاملresponse to neoadjuvant chemotherapy in locally advanced gastric and gastroesophageal cancer: phase ii clinical trial
background: gastric cancer is an important health problem across the world. chemotherapy in combination with local treatment is standard treatment for locally advanced gastroesophageal cancers. the purpose of this investigation was evaluation of response and tolerability to neoadjuvant eox regimen in locoregionally advanced gastric cancer. materials and methods: patients with locoregionally adv...
متن کاملInterstitial Brachytherapy for Locally Advanced Cervical Cancer
C l i n M e d International Library Citation: Denlinger N, Nolan N, Bixel K, Salani R, Martin D, et al. (2015) Interstitial Brachytherapy for Locally Advanced Cervical Cancer. Int J Womens Health Wellness 1:003 Received: September 16, 2015: Accepted: October 19, 2015: Published: October 21, 2015 Copyright: © 2015 Denlinger N. This is an open-access article distributed under the terms of the Cre...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
iranian journal of cancer preventionجلد ۶، شماره ۴، صفحات ۰-۰
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023